HF 2099:

-Prohibits retaliation by a PBM against a pharmacy based on the pharmacy's exercise of any right or remedy, or on the pharmacy's cooperation with the commissioner. 

-PBM prohibited from assessing, charging, or collecting any form of renumeration that passes from any pharmacist, regardless of whether the pharmacist is in a pharmacy network.

-For each maximum allowable cost list that a PBM uses, a PBM shall update the maximum allowable cost list within seven days from the date of an increase of 10 percent or more in the national average drug acquisition cost of a prescription drug on the list. 

-Requires that the annual report provided by a PBM to the commissioner of insurance regarding prescription drug benefits provided to covered persons of each third-party payor with whom the PBM has contracted during the prior calendar year be in a format that does not publicly disclose the identity of a specific third-party payor, the price charged by a specific pharmaceutical manufacturer for prescription drugs, or the amount of rebates provided for prescription drugs.